Major investment for respiratory diseases completed

Major investment for respiratory diseases completed105 million euros invested into expansion of production facilities in Ingelheim and DortmundEuropean launches of next-generation inhaler kicked off 
Source: Boehringer Ingelheim Corporate News - Category: Research Source Type: news